Mokosak Advisory Group LLC Has $332,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mokosak Advisory Group LLC cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 636 shares of the medical equipment provider’s stock after selling 304 shares during the quarter. Intuitive Surgical accounts for about 0.1% of Mokosak Advisory Group LLC’s portfolio, making the stock its 23rd largest holding. Mokosak Advisory Group LLC’s holdings in Intuitive Surgical were worth $332,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently issued reports on ISRG shares. Royal Bank of Canada boosted their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Mizuho boosted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock worth $15,357,560 in the last three months. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $578.55 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $206.07 billion, a P/E ratio of 90.26, a P/E/G ratio of 5.51 and a beta of 1.39. The stock’s 50 day moving average price is $550.40 and its 200 day moving average price is $510.02.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.